Detection of Metastatic Disease in Prostate Cancer: Past, Present, Future

Detection of Metastatic Disease in Prostate Cancer: Past, Present, Future.  

Philip Koo discusses the evolving use of imaging in the detection of bone metastasis in the prostate cancer patient.  

Phillip Koo, MD
Associate Professor, Radiology - Nuclear Medicine
University of Colorado School of Medicine
Aurora, Colorado

Dr. Koo is the associate professor of radiology, nuclear medicine at the University of Colorado School of Medicine. He is a graduate of Drexel University College of Medicine and is a Fellow at the Brigham and Women's Hospital/Children's Hospital/Harvard Medical School Program. A member of the American College of Radiology (ACR), Radiological Society of North America (RSNA), and Society of Nuclear Medicine (SNM), Dr. Koo has also been recognized as a "Top Doctor" the past three years (2013 - 2015) in 5280 Magazine, a local magazine for and about the Denver area. In addition, Dr. Koo was the recipient of the Ursula Mary Kocemba-Slosky Award, SNMMI/ERF, in 2015, which represents the Society of Nuclear Medicine and Medical Imaging's commitment to advancing molecular imaging and therapy by supporting the next generation of researchers.